Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative ...

A study found that combining the active ingredient extracted from the traditional Chinese medicine Astragalus membranaceus with the widely used Western drug methotrexate can effectively reduce chronic ...

SH-110, a liquid cancer treatment for glioma, earned orphan drug status from the FDA, helping patients who struggle to ...

When standard cancer treatments begin to fail, especially in aggressive or advanced stages, oncologists are increasingly ...

Accord Healthcare resumes making methotrexate Accord Healthcare, a London-based drugmaker, resumed manufacturing of two methotrexate solutions, according to a Nov. 7 update from the FDA.

Medically reviewed by Katlein Franca, MD Guttate psoriasis causes small, round bumps. It's typically triggered by a Streptococcus (strep) bacteria infection. Guttate psoriasis most commonly affects ...

We treated 428 patients who had active rheumatoid arthritis despite methotrexate therapy with placebo or infliximab, a chimeric monoclonal antibody against TNF-α, in intravenous doses of 3 or 10 ...

Compared with placebo, adding methotrexate nearly doubled steroid-free remission rates and reduced time to remission by 11 weeks.

Indian Defence Minister Rajnath Singh told his Chinese counterpart that the two countries should seek a "permanent solution" to their decades-old border dispute, in a new push for a conclusive ...

The U.S. FDA has accepted a Biologics License Application (BLA) for BAT2506, a proposed biosimilar to Simponi (golimumab).

Discover how targeted therapies are revolutionizing autoimmune disease treatment by offering greater precision.